Skip to main content
Premium Trial:

Request an Annual Quote

Japan's NGK Licenses OGT's Oligo IP to Develop, Sell Microarrays

NEW YORK (GenomeWeb News) – Japan’s NGK Insulators has licensed from Oxford Gene Technology patents for oligonucleotide microarrays in order to manufacture its own arrays, OGT said today.
 
The Japanese company will make the arrays using a technology called Geneshot, which uses piezoelectric ceramic microactuators. NGK can sell these OEM and NGK-branded microarrays in Japan.
 
The license will remain valid for the patents’ lifetime.
 
Financial details were not disclosed.          

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more